Medically Reviewed

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles
6) Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated September 7th, 2022

PARP Inhibitors for Ovarian Cancer: What to Expect

SN Local - Explore Ovarian Cancer expertise and community near you:

NOW
PLAYING
Zanubrutinib May Delay Disease Progression in Chronic Lymphocytic Leukemia & Small Lymphocytic Lymphoma
NOW
PLAYING
For Father Of Four, 43, Soreness From New Orange Theory Gym Kick Turned Out To Be Cancer
NOW
PLAYING
What Do Doctors Look For As Patients Undergo Oral Treatment (TKIs) For CML?
NOW
PLAYING
Tyrosine Kinase Inhibitors — Game-Changing Drugs for Chronic Myeloid Leukemia
NOW
PLAYING
Real-World Implications Of Her2 Low- The Major New Breast Cancer Designation And Its Treatment-- How Low Is Too Low?
NOW
PLAYING
Changing Landscape Of Ovarian Cancer Treatment: PARP Inhibitor Drugs Withdrawn For Some Indications

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... ovarian cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Maintenance: PARP Inhibitors as a Maintenance Tool

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.